A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Lifestyle.INQ on MSN
I used AI to create a health plan for me
Despite having plenty of information and knowledge, I struggled to put everything together, so I turned to AI to help create ...
As regulatory pressure increases, chemical companies are turning to AI to identify and replace PFAS and other restricted ...
The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.
Experienced network designers know that the performance achievable of a data link depends on many factors, including the ...
Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...
The National Council on Disability Affairs (NCDA) is intensifying enhancements to the unified persons with disability (PWD) ...
TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
The ovarian hormone estradiol plays a key role in shaping how the brain responds to perceived threats after trauma in women ...
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback